LivaNova Change in Accounts Receivable 2010-2025 | LIVN
LivaNova change in accounts receivable from 2010 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
| LivaNova Annual Change in Accounts Receivable (Millions of US $) |
|
|---|---|
| 2024 | $11 |
| 2023 | $-29 |
| 2022 | $-5 |
| 2021 | $-16 |
| 2020 | $59 |
| 2019 | $-5 |
| 2018 | $21 |
| 2017 | $-49 |
| 2016 | $-16 |
| 2015 | $N/A |
| 2015 | $-3 |
| 2014 | $-11 |
| 2013 | $-10 |
| 2012 | $-1 |
| 2011 | $-2 |
| 2010 | $-4 |
| 2009 | $-3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $2.375B | $1.253B |
| LivaNova PLC is a medical technology company which focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company's operating units consists of Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. LivaNova PLC, formerly known as Cyberonics, Inc., is based in London, United Kingdom. | |||